Yao Xiao

Validation of published nomograms and accordingly individualized induction chemotherapy in nasopharyngeal carcinoma.

Jun Ma, X. Lan, Lu-ning Zhang, 2017, Oral oncology.

Retrospective Analysis of the Survival Benefit of Induction Chemotherapy in Stage IVa-b Nasopharyngeal Carcinoma

Xue-bin Zou, X. Lan, P. OuYang, 2016, PloS one.

Outcomes of adding induction chemotherapy to concurrent chemoradiotherapy for stage T3N0-1 nasopharyngeal carcinoma: a propensity-matched study

Xue-bin Zou, X. Lan, P. OuYang, 2017, OncoTargets and therapy.

Outcomes of Induction Chemotherapy Plus Intensity-Modulated Radiotherapy (IMRT) Versus IMRT Plus Concurrent Chemotherapy for Locoregionally Advanced Nasopharyngeal Carcinoma: A Propensity Matched Study

Wuguo Deng, X. Lan, Xicheng Wang, 2016, Translational oncology.

External validity of a prognostic nomogram for locoregionally advanced nasopharyngeal carcinoma based on the 8th edition of the AJCC/UICC staging system: a retrospective cohort study

K. You, Lu-ning Zhang, P. OuYang, 2018, Cancer communications.

Evaluation of Body Mass Index and Survival of Nasopharyngeal Carcinoma by Propensity-Matched Analysis

Jun Ma, Yuan-hong Gao, X. Lan, 2016, Medicine.

Age at diagnosis indicated poor prognosis in locoregionally advanced nasopharyngeal carcinoma.

Wuguo Deng, X. Lan, Xicheng Wang, 2015, Oncotarget.

Validation and comparison of the 7th and 8th edition of AJCC staging systems for non-metastatic nasopharyngeal carcinoma, and proposed staging systems from Hong Kong, Guangzhou, and Guangxi.

X. Lan, K. You, Lu-ning Zhang, 2017, Oral oncology.

Effect of intensity-modulated radiotherapy versus two-dimensional conventional radiotherapy alone in nasopharyngeal carcinoma

Jun Ma, R. Sun, Wuguo Deng, 2016, Oncotarget.

Clinical Characteristics, Prognostic Factors, and Treatment Modalities for Head and Neck Lymphoepithelioma-like Carcinoma: A Real-world Study from Southern China.

Y. Mao, Yan-fen Feng, Yao Xiao, 2023, Radiotherapy and oncology : journal of the European Society for Therapeutic Radiology and Oncology.